Chronic viral hepatitis with concurrent metabolic dysfunction-associated steatotic liver disease: dual etiology challenges
Clinical and Molecular Hepatology · 30.09.2026 · 32 (Suppl) · e2026.0387
DOI: 10.3350/cmh.2026.0387 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical and Molecular Hepatology, erschienen am 30.09.2026. Verfasst von Shang-Chin Huang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, National Taiwan University Hospital Bei-Hu Branch, Taipei, Taiwan. Hauptthemen laut MEDLINE: Fatty Liver, Hepatitis C, Chronic, Hepatitis B, Chronic. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 138 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
The overlapping epidemics of chronic viral hepatitis and metabolic dysfunction-associated steatotic liver disease (MASLD) present a complex challenge in modern hepatology. In chronic hepatitis B, a unique “steatosis paradox” emerges: while isolated hepatic steatosis provides a suppressive microenvironment that promotes hepatitis B viral clearance, the concomitant systemic cardiometabolic burden acts dose-dependently to drive fibrogenesis and hepatocellular carcinoma (HCC). Conversely, chronic hepatitis C and host metabolic dysfunctions exhibit synergistic destruction. Hepatitis C virus actively hijacks lipid metabolism and induces insulin resistance. Even after viral eradication via direct-acting antivirals, residual steatosis and glycemic abnormalities remain formidable drivers of HCC. Consequently, the traditional virocentric paradigm is no longer sufficient. Clinical management should pivot toward precision risk stratification and a multidisciplinary dual-target approach, equally prioritizing sustained viral suppression and aggressive metabolic remission. This review summarizes the divergent virus-MASLD interactions, optimal clinical strategies, current challenges and future opportunities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, National Taiwan University Hospital Bei-Hu Branch, Taipei, Taiwan.
- Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
- Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
- Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
- Department of Physical Therapy and Assistive Technology, National Yang Ming Chiao Tung University, Taipei, Taiwan.
- Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan. cjliu@ntu.edu.tw.
Zitieren
APA
Huang, S. C., Shih, Y. F., & Liu, C. J. (2026). Chronic viral hepatitis with concurrent metabolic dysfunction-associated steatotic liver disease: dual etiology challenges. Clinical and Molecular Hepatology, 32(Suppl), e2026.0387. https://doi.org/10.3350/cmh.2026.0387
Vancouver
Huang SC, Shih YF, Liu CJ. Chronic viral hepatitis with concurrent metabolic dysfunction-associated steatotic liver disease: dual etiology challenges. Clinical and Molecular Hepatology. 2026;32(Suppl):e2026.0387. doi:10.3350/cmh.2026.0387
BibTeX
@article{Huang2026,
author = {Huang, Shang-Chin and Shih, Yi-Fen and Liu, Chun-Jen},
title = {Chronic viral hepatitis with concurrent metabolic dysfunction-associated steatotic liver disease: dual etiology challenges},
journal = {Clinical and Molecular Hepatology},
year = {2026},
volume = {32},
number = {Suppl},
pages = {e2026.0387},
doi = {10.3350/cmh.2026.0387}
}
EUVIMED